Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or calcitonin gene-related peptide monoclonal antibodies
Journal of Managed Care & Specialty Pharmacy | September 30, 2023 | Volume: 29 | Issue: 10 | Pages: 1119-1128
10.18553/jmcp.2023.29.10.1119
| PMID 37776119